IP Library Granted Patent US 10,821,223
Granted Patent B2
US 10,821,223 · App. 15/878,669 · Granted Nov 3, 2020

Liquid infusion apparatus

Inventor: Roger E. Susi (Winter Park, FL)
Assignee: IRADIMED CORPORATION
A61M5/142A61M5/14228A61M5/172F04B43/082A61M5/1413A61M39/26A61M2205/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,821,223
App. No.
15/878,669
Granted
Nov 3, 2020
Kind
B2
Abstract

An apparatus and method are disclosed for controlling infusion of liquid into a patient using a peristaltic pump. The liquid infusion apparatus includes a liquid conduit having a proximal segment, a distal segment and an intermediate segment. The liquid infusion apparatus also includes a flow valve in fluid communication with the intermediate and distal segments. The flow valve includes a shuttle member slidably disposed within a housing about the distal segment, the shuttle member being configured for lateral movement relative to an elongated axis of the distal segment. The shuttle member is configured to operate in a first configuration to impede fluid flow through the liquid conduit and in a second configuration for which fluid flow through the liquid conduit is unimpeded. The shuttle member includes a resilient grasper for selectively engaging and disengaging a mating actuator resiliently received by the grasper.

Claims (30)

1. An intravenous (IV) liquid infusion apparatus, comprising:

a two phase ultrasonic motor configured to provide displacement of an IV liquid from an IV liquid source through a liquid conduit via peristaltic pumping elements configured to directly contact the liquid conduit to cause the displacement of the IV liquid;

an oscillator that generates an output at a controllable frequency;

a circuit configured to receive the output from the oscillator and produce recurring pulses representative of sine and cosine phases;

a timer having an associated time constant that causes a finite sweeping of the controllable frequency of the output when a motor control signal indicates that the ultrasonic motor is to start running;

a feedback signal indicative of current speed of the ultrasonic motor,

wherein the feedback signal operates in combination with the timer to control sweeping of the the controllable frequency of the output; and

a high voltage driver associated with each of the sine and cosine phases that provides the ultrasonic motor with two phase drive power,

wherein the feedback signal is continuously detected while the two phase drive power is being applied to the ultrasonic motor so as to provide continuous modulation of a speed of the ultrasonic motor.

2. The liquid infusion apparatus of claim 1 , wherein the displacement of the liquid through the IV liquid conduit is linear.

3. The liquid infusion apparatus of claim 1 , wherein the sweeping of the oscillator is from a higher frequency to a lower frequency.

4. The liquid infusion apparatus of claim 3 , wherein the higher frequency is useful for starting the ultrasonic motor from a standstill and the lower frequency is an appropriate frequency to establish a steady-state motor speed.

5. The liquid infusion apparatus of claim 1 , wherein the displacement of the IV liquid through the liquid conduit provides a constant fluid flow rate.

6. The liquid infusion apparatus of claim 1 , wherein the liquid infusion apparatus is compatible with an MM environment.

7. The liquid infusion apparatus of claim 1 , further comprising a conductive housing that inhibits internally-generated RF noise signals from radiating out of the liquid infusion apparatus.

8. An intravenous (IV) liquid infusion apparatus, comprising:

a two phase ultrasonic motor configured to provide displacement of an IV liquid from an IV liquid source through a liquid conduit via mechanical linkage to actuate one or more pump elements configured to contact the liquid conduit to cause the displacement of the IV liquid;

an oscillator that generates an output at a controllable frequency;

a circuit configured to receive the output from the oscillator and produce recurring pulses representative of sine and cosine phases;

a timer having an associated time constant that causes a finite sweeping of the controllable frequency of the output when a motor control signal indicates that the ultrasonic motor is to start running;

a feedback signal indicative of current speed of the ultrasonic motor,

wherein the feedback signal operates in combination with the timer to control sweeping of the the controllable frequency of the output; and

a high voltage driver associated with each of the sine and cosine phases that provides the ultrasonic motor with two phase drive power,

wherein the feedback signal is continuously detected while the two phase drive power is being applied to the ultrasonic motor so as to provide continuous modulation of a speed of the ultrasonic motor.

9. The liquid infusion apparatus of claim 8 , wherein the displacement of the IV liquid through the liquid conduit is linear.

10. The liquid infusion apparatus of claim 8 , wherein the sweeping of the oscillator is from a higher frequency to a lower frequency.

11. The liquid infusion apparatus of claim 10 , wherein the higher frequency is useful for starting the ultrasonic motor from a standstill and the lower frequency is an appropriate frequency to establish a steady-state motor speed.

12. The liquid infusion apparatus of claim 8 , wherein the displacement of the IV liquid through the liquid conduit provides a constant fluid flow rate.

13. The liquid infusion apparatus of claim 8 , wherein the liquid infusion apparatus is compatible with an MM environment.

14. The liquid infusion apparatus of claim 8 , further comprising a conductive housing that inhibits internally-generated RF noise signals from radiating out of the liquid infusion apparatus.

Continuity (4)
Continuation 13923082 · Jun 20, 2013
Continuation 12494166 · Jun 29, 2009
Division 11271705 · Nov 10, 2005
Related Publication 20180236161A1 · Aug 23, 2018
Cited By (2)
US 12,246,165 US 12,251,534